Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective.
Asrul Akmal ShafieJacqueline Hui Yi WongHishamshah Mohd IbrahimNoor Syahireen MohammedIrwinder Kaur ChhabraPublished in: Orphanet journal of rare diseases (2021)
The lifetime cost per TDT patient was USD 606,665, and this result may be useful for national health allocation planning. An estimation of the economic burden will provide additional information to decision makers on implementing prevention interventions to reduce the number of new births and medical service reimbursement.